Assess portfolio success probabilities at each phase and optimize resource allocation

Continually monitor competitive landscape for growth opportunities

Identify optimal clinical trial designs and endpoints for asset advancement

Prioritize candidates based on likelihood of regulatory approval

Clear insights into growth and financial opportunity

Candidate evaluation - Forecast clinical/regulatory success, indication feasibility

Trial design - Select optimal phase lengths, size, endpoints, and control arms

Due diligence - Rapidly benchmark asset potential and valuation

Portfolio management - Continual optimization of development investments

Lifecycle management - Indication expansion, repurposing, next best steps

Competitive Intelligence - Provide highly detailed competitive intelligence and analytics

Rapidly access, interpret, and apply regulatory standards at scale

Automate gap analyses to align SOPs with internal and external requirements

Research precedents and stay current with changing global regulations

Generate draft submissions tailored to regional requirements in real time

Instantly access training procedures, reports, and other documentation

Cross-reference issues and proactively identify process improvements

Quality assurance - Conduct automated GAP analyses, access procedures/training, generate reports

Regulatory affairs - Research submissions precedents, create tailored draft filings

Clinical operations - Access protocols/training, optimize trial design, enrollment planning

Pharmacovigilance - Surface safety signals, adverse event reporting

Manufacturing - Accelerate tech transfers, batch record reviews, change controls

Accelerate development timelines through automated regulatory document creation and data analysis

Optimize large portfolios by accurately predicting success probabilities for each asset

Prioritize lifecycle management opportunities such as indication expansion

Improve productivity of regulatory submissions and publishing

Enhance safety signal detection and pharmacovigilance

Reduce late phase failure rates through optimized trial design

Provide highly detailed competitive intelligence and analytics

Guide clinical trial design and planning to maximize asset value

Benchmark potential of early targets and make data-driven "go/no go" decisions on candidates

Refine enrollment criteria and dosing using advanced patient profiling

Identify optimal combination therapies and repurposing opportunities

Quantify asset value for investment/partnership decisions

Expedite and maximize strategic funding

Avoid costly pivots through continually updated risk assessments

Rapidly design and optimize trials leveraging insights into precedents and high-value endpoints

Assess competitive landscape to identify differentiation opportunities in trial offerings

Accelerate study start-up through instant access to protocols and procedures

Strengthen client partnerships via trials uniquely customized to each asset

Refine patient recruitment strategy using advanced analytics

Unique value-add in winning and onboarding new clients

Identify process improvement opportunities via instant access to procedures and training

Optimize and customize formulations

Maintain optimum quality and compliance standards

Improve speed in batch record review and changeover procedures

Dosage form and delivery innovation

Manufacturing process optimization

Regulatory management support

Unique value-add in winning and onboarding new clients

Conduct rapid opportunity assessments and benchmarking for assets

Quantify addressable market size, competitor landscape, and growth drivers

Identify optimal trial endpoints, size, duration to maximize asset value

Assess leadership, operational excellence, and partnership compatibility

Create risk-adjusted valuations supported by predicted success rates

Evaluate commercial positioning, and go-to-market strategy

Produce detailed landscaping of technological, regulatory, and R&D trends

Unique value-add in winning and onboarding new clients